Regulatory T cells (Tregs) play a major role in establishing and maintaining immune tolerance in tissues, with a predilection for epithelial barriers such as skin. Augmenting the function of these cells has significant potential to treat cutaneous inflammation and inhibiting the function of these cells may prove efficacious in treating cutaneous malignancies. We recently characterized a unique population of Tregs in both murine and human skin, termed memory Tregs (mTreg). These cells are highly activated suppressors that are stably maintained in skin for relatively long periods of time and have enhanced functional capacity to attenuate inflammation. The underlying theme of this proposal is to functionally dissect the dominant pathways utilized by mTregs in skin and develop novel strategies to specifically augment or inhibit the function of these cells in a tissue-specific fashion. To achieve this goal, we will utilize novel technological advances in our ability to disset the function of immune cells in human skin in vivo. This is a high-risk high-reward proposal with the potential for direct translation to human disease. Its innovativeness stems from the fact that we will utilize newly established transgenic mouse model systems to inform experiments in humanized mice, enabling us to effectively and efficiently translate findings from mice to humans. On a basic level, we will gain critical mechanistic insight as to how mTregs function in skin and, on a translational level, we will exploit this knowledge to develop new treatment strategies for inflammatory or malignant skin disease.
Local tissue-specific therapies that enhance the body's immune system have the potential to resolve inflammation and eradicate cancer with minimal systemic side effects. The overall goal of this grant application is to understand how the immune system functions in the skin. Using this knowledge we will develop new strategies to enhance the skin's immune system to treat chronic inflammatory skin diseases and skin cancer.
|Ali, Niwa; Zirak, Bahar; Truong, Hong-An et al. (2018) Skin-Resident T Cells Drive Dermal Dendritic Cell Migration in Response to Tissue Self-Antigen. J Immunol 200:3100-3108|
|Barry, Kevin C; Hsu, Joy; Broz, Miranda L et al. (2018) A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat Med 24:1178-1191|
|Chang, Hsin-Wen; Yan, Di; Singh, Rasnik et al. (2018) Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization. Microbiome 6:154|
|Wang, David; Quiros, Jason; Mahuron, Kelly et al. (2018) Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. Cell Rep 23:3262-3274|
|Ahn, Richard; Yan, Di; Chang, Hsin-Wen et al. (2018) RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways. Sci Rep 8:11368|
|Mande, Purvi; Zirak, Bahar; Ko, Wei-Che et al. (2018) Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation. J Clin Invest 128:2966-2978|
|Scharschmidt, Tiffany C; Vasquez, Kimberly S; Pauli, Mariela L et al. (2017) Commensal Microbes and Hair Follicle Morphogenesis Coordinately Drive Treg Migration into Neonatal Skin. Cell Host Microbe 21:467-477.e5|
|Loo, Kimberly; Tsai, Katy K; Mahuron, Kelly et al. (2017) Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy. JCI Insight 2:|
|Ali, Niwa; Zirak, Bahar; Rodriguez, Robert Sanchez et al. (2017) Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation. Cell 169:1119-1129.e11|
|Ahn, Richard S; Taravati, Keyon; Lai, Kevin et al. (2017) Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin. Sci Rep 7:1343|
Showing the most recent 10 out of 18 publications